Product Information

OXCARBAZEPINE 150 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.1037 per EA under NDC 60687071101. Its NADAC has been published 183 times since Feb 22, 2023.

FDA first approved this application on Jan 11, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXCARBAZEPINE 150 MG TABLET

Oxcarbazepine
$0.1037per EA

Strength

150 mg/1

NDC

60687071101

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

OXCARBAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA215939

FDA Approved

1/11/2022

TE Code

AB

On Market Since

2/2/2023

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for OXCARBAZEPINE 150 MG TABLET has been published 183 times since Feb 22, 2023, and over the history we have for it it has declined 26.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1037 per EA
All-time high$0.1447 (Feb 14, 2024)
All-time low$0.1035 (Nov 20, 2024)
52-week high$0.1183
52-week low$0.1036
Median price$0.1252
Average price$0.1245
Largest weekly change-26.2% (Nov 20, 2024)
Weeks tracked183
Tracking sinceFeb 22, 2023

Price History

1W

+0.0%

1M

+0.0%

3M

-3.2%

6M

-4.6%

1Y

-11.8%

3Y

-24.8%

5Y

N/A

All

-26.1%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OXCARBAZEPINE 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 150 MG TABLET, manufactured by American Health Packaging, is $0.1037 per EA (NDC 60687071101), effective Aug 19, 2026.

How has the price of OXCARBAZEPINE 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXCARBAZEPINE 150 MG TABLET has declined 26.1%. It has been tracked across 183 weekly CMS publications since Feb 22, 2023.

What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 150 MG TABLET?

Since Feb 22, 2023, the NADAC for OXCARBAZEPINE 150 MG TABLET has ranged from a low of $0.1035 (Nov 20, 2024) to a high of $0.1447 (Feb 14, 2024), with a median of $0.1252 per EA.

Are there cheaper alternatives to OXCARBAZEPINE 150 MG TABLET?

8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXCARBAZEPINE 150 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures OXCARBAZEPINE 150 MG TABLET?

OXCARBAZEPINE 150 MG TABLET (NDC 60687071101) is labeled by American Health Packaging, and CMS classifies it as a generic product.